Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with ...

Researchers identified how leptin, a hormone from fat cells, fuels estrogen receptor-positive breast cancer. The study found ...

Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen ...

Scientists tracked how the body reorganized its chemistry across an entire week of fasting, not just on day one and day seven ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Your body maintains a biological “set point” for weight, beyond calories, through powerful hormonal and neural feedback loops that make it resist weight loss.

The Food and Drug Administration has extended the review period for setmelanotide in the treatment of acquired hypothalamic obesity.

Significant progress on multiple fronts - obesity pipeline advancing towards the clinic, out-licensing collaboration, strengthened balance sheet, and reinstatement ...

The annual conference presented over 100 scientific sessions featuring innovations from leading pharmaceutical companies, including ...